Viome vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Viome uses proprietary RNA sequencing and AI on the world's largest microbiome dataset (600K+ samples) to deliver personalized supplements and health tests; raised $175M total including a CVS distribution deal.
About
Viome is a precision health company that combines proprietary RNA sequencing technology with artificial intelligence to analyze the human microbiome and provide personalized nutrition and health recommendations. Founded by serial entrepreneur Naveen Jain and headquartered in Bothell, Washington, Viome has built the world''s largest RNA sequencing database from the human microbiome, containing over 600,000 samples from customers and clinical research participants. The company''s at-home test kits — including the Full Body Intelligence Test, Gut Intelligence Test, and Oral Health Intelligence Test — analyze gut, oral, and systemic microbiome health to identify imbalances and inflammation pathways.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.